Clinical Trials
4 trialsNCT04590963 2026-06-01
INTERLINK-1
AstraZeneca
Phase 3 Active not recruiting
NCT05061550 2026-05-22
NeoCOAST-2
AstraZeneca
Phase 2 Recruiting
NCT05221840 2026-05-18
PACIFIC-9
AstraZeneca
Phase 3 Active not recruiting
NCT02671435 2025-07-22
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
MedImmune LLC
Phase 1/2 Active not recruiting